U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07131059) titled 'MRD-positive AML Clinical Study' on May 12, 2024.
Brief Summary: This clinical trial is a platform-type clinical study intended to investigate the efficacy and safety of MRD-positive acute myeloid leukemia patients after comprehensive treatment, which includes but is not limited to the following drugs and protocols: Chemotherapy, small molecule targeted drugs, demethylation drugs, liposome drugs and the combination of these drugs to form a combination of treatment regimen, the specific treatment regimen will be updated according to the results of this trial and the latest research progress at home and abroad.
Study Start Date: May ...